In accordance with expectation but perfectly logically and reasonably, the data showed that FOXA1, RASGRP3 and FOXN3 all have elevated expression in normal tissues and decreased expression in NPC tissues (Figure 7A). The gene discussed is FOXA1; the disease is nasopharyngeal carcinoma.